The potential impact on children of the CDC guideline for prescribing opioids for chronic pain: Above all, do no harm

JAMA Pediatrics

Volumn 170, Issue 5, 2016, Pages 425-426

  Schechter, Neil L ^a,b   Walco, Gary A ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

CHRONIC PAIN; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EDITORIAL; EPIDERMOLYSIS BULLOSA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LONG TERM CARE; MEDICAL DOCUMENTATION; NEUROMUSCULAR DISEASE; OPIATE ADDICTION; OSTEOGENESIS IMPERFECTA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; CHILD; CLINICAL PRACTICE; HEALTH PERSONNEL ATTITUDE; PUBLIC HEALTH SERVICE;

ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CHRONIC PAIN; HUMANS; PRACTICE PATTERNS, PHYSICIANS';

EID: 84965134140     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2016.0504     Document Type: Editorial

References (13)

1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016 [published online March 15, 2016]. JAMA. doi:10.1001/jama.2016.1464.
2. Interagency Pain Research Coordinating Committee. National Pain Strategy: A comprehensive population health-level strategy for pain. http://iprcc.nih.gov/docs/drafthhsnationalpainstrategy.pdf. Accessed May 19, 2015.
3. Fortuna RJ, Robbins BW, Caiola E, Joynt M, Halterman JS. Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics. 2010;126(6):1108-1116.
4. Substance Abuse and Mental Health Services Administration. Results From the 2012 National Survey on Drug Use and Health (NSDUH): Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. NSDUH Series H-46, US Dept of Health and Human Services Publication SMA13-4795.
5. Injury prevention & control: Prescription drug overdose. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugoverdose/data/overdose.html. Accessed February 8, 2016.
6. Zosel A, Bartelson BB, Bailey E, Lowenstein S, Dart R. Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-related Surveillance (RADARS(® )) System. J AmAcad Child Adolesc Psychiatry. 2013;52(2):196-204.
7. Califf RM,Woodcock J, Ostroff S. A proactive response to prescription opioid abuse [published online February 4, 2016]. N Engl J Med. doi:10.1056/NEJMsr1601307.
8. Schechter NL. Pediatric pain management and opioids: The baby and the bathwater. JAMA Pediatr. 2014;168(11):987-988.
9. FitzgeraldM. The development of nociceptive circuits. Nat Rev Neurosci. 2005;6(7):507-520.
10. Grunau RE. Long-term effects of pain in children. In:McGrath PJ, Stevens BJ,Walker SM, ZempskyWT, eds. Oxford Textbook of Paediatric Pain. Oxford, England: Oxford University Press; 2014:30-38.
11. Becerra L, Sava S, Simons LE, et al. Intrinsic brain networks normalize with treatment in pediatric complex regional pain syndrome. Neuroimage Clin. 2014;6:347-369.
12. Berde CB,Walco GA, Krane EJ, et al. Pediatric analgesic clinical trial designs, measures, and extrapolation: Report of an FDA scientific workshop. Pediatrics. 2012;129(2):354-364.
13. Walco GA. Managing chronic non-cancer pain in children and adolescents. In:Washington State Agency Medical Directors' Group, eds. Interagency Guideline on Prescribing Opioids for Pain; 2015:45-47. http://www.agencymeddirectors.wa .gov/Files/2015AMDGOpioidGuideline.pdf. Accessed February 24, 2016.